Cargando…
PB2115: TRIAL IN PROGRESS: A RANDOMIZED PHASE II STUDY OF MB-CART2019.1 COMPARED TO STANDARD OF CARE THERAPY IN PATIENTS WITH RELAPSED/REFRACTORY DLBCL INELIGIBLE FOR AUTOLOGOUS STEM CELL TRANSPLANTATION
Autores principales: | Borchmann, P., Vandenberghe, P., Urbano, A., Haioun, C., Lemonnier, F., Griškevicius, L., Maury, S., Holtkamp, S., Friedrichs, B., Zadoyan, G., Hanssens, L., Brillant, C., Bethke, U., Assenmacher, M., Bürger, I., Philippe, B., Overstijns, T., Jäger, U., Kersten, M. J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9431412/ http://dx.doi.org/10.1097/01.HS9.0000851292.41035.e8 |
Ejemplares similares
-
P1184: PHASE I TRIAL OF MB-CART2019.1 IN PATIENTES WITH RELAPSED OR REFRATORY B-CELL NON-HODGKIN LYMPHOMA: 2 YEAR FOLLOW-UP REPORT
por: Borchmann, P., et al.
Publicado: (2022) -
Mastering Tableau 2019.1: an expert guide to implementing advanced business intelligence and analytics with Tableau 2019.1
por: Meier, Marleen, et al.
Publicado: (2019) -
PROJECT ADMINISTRATION AGREEMENT KN2115/EN
por: THE EUROPEAN ORGANIZATION FOR NUCLEAR RESEARCH, CERN, et al.
Publicado: (2013) -
Seroprevalence of SARS-CoV-2 antibodies in 2115 blood donors from Romania
por: Olariu, Tudor Rares, et al.
Publicado: (2021) -
2115. Long Term Follow-up and Correlates of Success in Patients on Immune Globulin for Antibody Deficiency
por: Duffield, Olivia, et al.
Publicado: (2022)